What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the estimated listing price for Entero Healthcare Solutions Limited IPO?

Based on the upper price band of ₹1258 and current GMP of ₹2, the estimated listing price is ₹1260 (approx. 0.2% gain).

What is the expected profit per lot for Entero Healthcare Solutions Limited IPO?

With a lot size of 11 shares and current GMP of ₹2, expected profit per retail application lot is approximately ₹22.

IPO GreyPremiumLIVE

Grey Market Intelligence

Entero Healthcare Solutions Limited

ListedMainboard

Industrial & Financial Services · NSE / BSE

Entero Healthcare Solutions Limited was founded in 2018 and is a leading distributor of healthcare products in India. Using a technology-driven platform, the company supplies healthcare products to pharmacies, hospitals, and clinics across the country. Key Highlights: Growing Customer Base: Served 39,500+ retail customers in 2021, 64,200+ in 2022, and 81,400+ in 2023. Also served 1,600+ hospitals in 2021, 2,500+ in 2022, and 3,400+ in 2023. Strong Manufacturer Network: Partnered with 1,900+ healthcare product manufacturers, offering access to 64,500+ product SKUs (as of March 31, 2023). Extensive Infrastructure: Operates 73 warehouses in 37 cities across 19 states and union territories, covering 495 districts in India. Large Workforce: As of March 31, 2023, the company has 3,014 employees across various departments. With its vast distribution network and strong industry relationships, Entero Healthcare Solutions continues to expand its reach in the healthcare sector.

Price Band

₹1195 – ₹1258

Issue Size

₹1600 Cr

Lot Size

11 shares

GMP

₹2

+0.2%

Est. Listing

₹1260

at current GMP

Subscribed

1.56x

overall

Open

9 Feb 2024

13 Feb 2024

Allotment

14 Feb 2024

Refund

15 Feb 2024

Demat Credit

16 Feb 2024

Listing

16 Feb 2024

Last updated 12 days ago

Overview Live GMP Live Subscription Allotment Status

Live Grey Market Premium

Entero Healthcare Solutions Limited GMP Today

Last updated: 19 Oct 2026

Current Premium

₹2+0.2%

Issue Price (Upper)

₹1258

Band: ₹1195 – ₹1258

Estimated Listing Price

₹1260

Upper price + GMP

Lot Size

11 shares

Min investment ₹13,838

Date	GMP (₹)	GMP %	Est. Listing
31 Oct 2026	+₹2	0.2%	₹1260
30 Oct 2026	+₹2	0.2%	₹1260
29 Oct 2026	+₹2	0.1%	₹1260

About Entero Healthcare Solutions Limited Public Issue & Market Profile

Entero Healthcare Solutions Limited is bringing an initial public offering (IPO) in the Industrial & Financial Services sector with an aggregate issue size of ₹1,600 Crores. The shares are offered at a price band of ₹1195 to ₹1258 per equity share on NSE and BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.

Public Issue & Pricing Context:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Basis of Allotment & Listing Timeline:

Following the close of bidding on 2024-02-13, the basis of allotment is scheduled to be finalized on 2024-02-14. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Link Intime India Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Entero Healthcare Solutions Limited IPO GMP today?

The latest grey market premium for Entero Healthcare Solutions Limited IPO is ₹2, which indicates an expected listing price of ₹1260.

What does Kostak Rate and Sauda mean in IPO GMP?

Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.

Is Grey Market Premium officially recognized?

No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.